Revised SPC: Biktarvy 50 mg/200 mg/25 mg (bictegravir/emtricitabine/tenofovir alafenamide fumarate) film-coated tablets

Stevens-Johnson Syndrome has been added to SPC as a rare adverse event.

Source:

electronic Medicines compendium